Rheumatology Informatics System for Effectiveness

Rheumatoid Arthritis Clinical Trial

— RISE  

Official title:

American College of Rheumatology's Rheumatology Informatics System for Effectiveness

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02230943
• Other study ID #: RISE
• Status: Recruiting
• Phase: N/A
• First received: August 29, 2014
• Last updated: August 29, 2014
• Start date: April 2014

Study information

• Verified date: August 2014
• Source: American College of Rheumatology
• Contact: Melissa D Francisco
• Phone: 404-633-3777
• Email: mfrancisco[@]rheumatology.org
• Is FDA regulated: No
• Health authority: Institutional Review Board: United States
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The RISE Registry is an enhanced version of the ACR's Rheumatology Clinical Registry (RCR) and allows for a simplified entry process, while establishing a best-in-class resource to manage your patient population and improve patient care.

RISE provides participants with an infrastructure for robust quality improvement activities leading to improved patient outcomes, patient population management and quality reporting related to rheumatic diseases and drug safety. RISE gives physicians and researchers the information they need to optimize patient outcomes, meet reporting requirements, and make discoveries that advance rheumatology.

Description:

RISE helps providers benchmark performances on key rheumatology clinical quality measures and align with best practice standards. The RISE benchmarking tool allows providers to view the details of their patient population against established rheumatology quality metrics. RISE allows access to aggregate data from other participating sites so providers can view their patient population in comparison to other RISE participants.

RISE is integrated into an electronic health records (EHR) system, bringing a single point of entry into one solution for filing for quality-based incentive payments, avoiding penalties, complying with reporting requirements and tracking caseloads for quality monitoring and improvement initiatives. RISE collects the data needed to meet current federal reporting requirements.

Participating in RISE helps push the field of rheumatology practice forward. RISE provides a source of information on patient outcomes and quality care for rheumatology leading to new discoveries, better understanding and a source of comparative effectiveness research.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100000
• Est. primary completion date: December 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients 18 years of age and older with one of the following diagnoses: rheumatoid arthritis, osteoarthritis, gout

Exclusion Criteria:

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Arthritis, Rheumatoid
• Gout
• Osteoarthritis
• Rheumatoid Arthritis

Locations

Country	Name	City	State
United States	American College of Rheumatology	Atlanta	Georgia

Sponsors (1)

Lead Sponsor	Collaborator
American College of Rheumatology

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Controlling High Blood Pressure	Percentage of patients 18-85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled (<140/90mmHg) during the measurement period.	one year	No